Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Ascelia Pharma Logo
Ascelia Pharma Growth Score
76
CB Rank
64687
Heat Score
77
Ascelia Pharma is a biotechnology company that provides novel drugs.
Founded
obfuscation
PublicPost-IPO Equity Malmö, Skane Lan, Sweden11-50 www.ascelia.com
Biotechnology
Health Care
Medical
Pharmaceutical
Overview

Ascelia Pharma
Total Funding
obfuscation
Growth Score
76
Heat Score
77

Total Funding
obfuscation
Post-IPO Equity raised
obfuscation
Growth Score76
-8 pts
in past quarter
Heat Score 77
11 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
See more interactive data and historical milestones on desktop for the best experience

About Ascelia Pharma

CB Rank
64687
Ascelia Pharma is a biotechnology company that provides novel drugs.
Founded
obfuscation
PublicPost-IPO Equity Malmö, Skane Lan, Sweden11-50 www.ascelia.com
Biotechnology
Health Care
Medical
Pharmaceutical

Funding Rounds

Post-IPO Equity
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation

Key People

Details

Legal Name Ascelia Pharma AB
Also Known As CMC Contrast
Operating Status Active
Stock Symbol  STO:ACE
Company Type For Profit
About the Company
Ascelia Pharma is a biotechnology company. The company is focused on orphan oncology treatments.
Phone Number +46 73-517-9118
Contact Email info@ascelia.com
Predictions & Insights

Growth Insight

See this Growth Insight
Ascelia Pharma is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Products & Services

Orviglance®
An MRI contrast agent designed to improve visualization of focal liver lesions in patients with rare cancer conditions.
Oncoral
An oral irinotecan chemotherapy drug candidate for treating rare cancer conditions, currently in clinical development.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 5
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Ascelia Pharma Logo
Post-IPO Equity - Ascelia Pharma
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Ascelia Pharma Logo
Post-IPO Equity - Ascelia Pharma
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Ascelia Pharma Logo
Post-IPO Equity - Ascelia Pharma
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Ascelia Pharma Logo
Post-IPO Equity - Ascelia Pharma
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Ascelia Pharma Logo
Post-IPO Equity - Ascelia Pharma
—
obfuscation
— Post-IPO Equity

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 5
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Ascelia Pharma Logo
Post-IPO Equity - Ascelia Pharma
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Ascelia Pharma Logo
Post-IPO Equity - Ascelia Pharma
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Ascelia Pharma Logo
Post-IPO Equity - Ascelia Pharma
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Ascelia Pharma Logo
Post-IPO Equity - Ascelia Pharma
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Ascelia Pharma Logo
Post-IPO Equity - Ascelia Pharma
—
obfuscation
— Post-IPO Equity

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 5 Contacts 8

Employee Profiles

News

News and Press

News•May 12, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 12, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 11, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 4, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

941
-72.3%
 in past month

IT Spend

$284.4KThis year, Ascelia Pharma is projected to spend $284.4K on IT, according to Aberdeen.

Total IP

17The intellectual property of Ascelia Pharma includes 3 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery. Additionally, Ascelia Pharma has registered 14 trademarks with the most popular class being 'Chemical substances', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Ascelia Pharma's headquarters? Ascelia Pharma is located in Malmö, Skane Lan, Sweden.Who invested in Ascelia Pharma? Ascelia Pharma has 5 investors including Oresund Healthcare Management and  Sunstone Life Science Ventures.When was the last funding round for Ascelia Pharma? Ascelia Pharma closed its last funding round on
obfuscation
from a Post-IPO Equity round.Who are Ascelia Pharma's competitors? Alternatives and possible competitors to Ascelia Pharma may include Avenzo Therapeutics, CellCentric, and  GE Healthcare.How much funding has Ascelia Pharma raised to date? Ascelia Pharma has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(9fd75b2 1)
|